Article
Mutant androgen receptors in prostatic tumors distinguish between amino-acid-sequence requirements for transactivation and ligand binding.
International journal of cancer - 15 Nov 1995
Peterziel H, Culig Z, Stober J, Hobisch A, Radmayr C, Bartsch G, Klocker H, Cato A C
Abstract excerpt
Mutant androgen receptors are thought to contribute to hormone resistance in prostate carcinoma. The part they play in this process, however, is ill-defined. Here we report on transactivation by 2 mutant androgen receptors from prostatic tumors with single amino-acid exchanges in their hormone-binding domains. These exchanges enhance the transactivation property of the receptors, particularly to androsterone and...
Topics
- Amino Acid Sequence
- Androgen Antagonists
- Animals
- Base Sequence
- Binding Sites
- Flutamide
- Haplorhini
- Ligands
- Male
- Methionine
- Molecular Sequence Data
